Guidelines Call for More Transparency on Hepatitis C Drug Costs

Updated guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America and the International Antiviral Society -USA attempt to provide an overview of hepatitis C virus treatments, including cost comparisons. Learn more here, login required. (Source: Medscape, 8/26/15)

You might also be interested in:

NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
PAI and BresMed Join Forces to Support Expanded Use of More… July 22, 2019
New Non-Profit Association Launches Free Guideline… January 16, 2019
Leveraging Technology to Reduce Costs in Clinical Trials June 30, 2019
Global Health Economics & Outcomes Research (HEOR) Services… October 23, 2019
Pharmerit Expands Market Access Support in Asia January 17, 2019
Biomarkers and Companion diagnostics: Payer Insights September 26, 2019